MedTrace Logo

Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial

NCT05311540 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2023-02-08

No results posted yet for this study

Summary

* Zinc (Zn) is a structural component of human body and is a crucial element for a wide variety of cascades that take place in almost all organ systems.
* Due to many reasons, preterm infants are generally believed to be naturally in a negative Zn balance during the early periods of life.
* Regulation of intestinal Zn absorption of preterms is unrelated to infant's Zn status.
* There still is a lack of knowledge in the possible relation of Zn deficiency and development of NEC and/or feeding intolerance in preterm infants.
* Even if Zn is studied as an adjunct treatment for neonates and young infants with sepsis and found to reduce treatment failure in these high risk population, data in preventing infectious diseases in preterm infants is still lacking.

Conditions

  • Preterm Infant
  • Effect of Drugs
  • Zinc Deficiency Disease

Interventions

DRUG

Zinc Sulfate

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    collaborator OTHER

  • Zekai Tahir Burak Women's Health Research and Education Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
7 Days
Max Age
9 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-14
Primary Completion
2015-03-02
Completion
2015-04-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311540 on ClinicalTrials.gov